According to researcher, the treatment offers improved retinal sensitivity, visual function, and mobility.
Ophthalmology Times: December 2022
Ophthalmologist discusses the impact of getting older on patients diagnosed with the disease.
CXL has been proven effective to treat patients with corneal ectasias.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Q&A: William F. Wiley, MD, on what BVI's trifocal IOL approval means for US premium vision options
2
What if? Ophthalmology without OCT – Part 1
3
AAO 2025: Ophthalmic World Leaders honors 2025 leadership awardees
4
ICYMI: AAO 2025 showcases new technologies and continued research
5
.png "Optometry Times"){kind=logo}
